CMS Off-Label Coverage Decision For Colorectal Cancer Rx Coming Soon
Executive Summary
The Centers for Medicare & Medicaid Services expects to release proposed national coverage determinations on off-label use of colorectal cancer drugs in the "near future," CMS Chief Medical Officer Sean Tunis, MD, said Sept. 30 at a CMS workshop in Baltimore
You may also be interested in...
Colorectal Cancer Policy Will Not Limit Current Off-Label Coverage, CMS Says
The Centers for Medicare & Medicaid Services' national coverage determination for four colorectal cancer therapies will not limit coverage of other off-label indications, the agency said
Colorectal Cancer Policy Will Not Limit Current Off-Label Coverage, CMS Says
The Centers for Medicare & Medicaid Services' national coverage determination for four colorectal cancer therapies will not limit coverage of other off-label indications, the agency said
CMS Developing Guidance On Coverage Decisions For Clinical Trials
The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries